Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hello Nature, formerly known as Italpollina, is a premier global biotechnology company dedicated to sustainable agriculture through the development of biostimulants, organic fertilizers, and beneficial microorganisms. The company leverages its proprietary Plant-Derived Peptides (PDP) technology to create products that enhance crop resilience and nutritional quality. With a robust R&D focus, Hello Nature produces a wide range of microbial inoculants, including mycorrhizal fungi and Trichoderma atroviride, which optimize soil health and nutrient uptake. Operating in over 80 countries, the firm maintains state-of-the-art manufacturing facilities in Italy and the United States. Their mission centers on supporting the circular economy and providing innovative solutions for the future of global food production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Italpollina.